Refractory Lymphoblastic Lymphoma
4 clinical trials · Condition
◉ Watch Refractory Lymphoblastic Lymphoma
| Record | Firm | Date |
|---|---|---|
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia (NCT03136146) | M.D. Anderson Cancer Center | 2017-08-09 |
| Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma (NCT01658007) | Children's Hospital Medical Center, Cincinnati | 2012-08-01 |
Track Refractory Lymphoblastic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.